Surgery Partners Inc (SGRY)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $3.53B
Last updated: Nov 17, 2026 at 11:06 AM ET
Surgery Partners Inc (SGRY) Stock Forecast
Analysts expect Surgery Partners (SGRY) to earn $0.37 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.20B. Of 7 analysts, 1 rates the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Hold. For the fiscal year ending Dec 31, 2027, the EPS consensus is $0.18.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.86, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 14% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 14.3% |
| Hold | 6 | 85.7% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 51.4% and revenue estimates fall 8.8%.
- Fiscal year ending Dec 31, 2026
- $0.37
- EPS consensus, revenue $3.20B
- Fiscal year ending Dec 31, 2027
- $0.18
- EPS consensus, revenue $2.92B
- Next report
- Mar 1, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.37 | $0.37 to $0.37 | 1 | $3.20B | $3.14B to $3.39B | 7 |
| Dec 31, 2027 | $0.18 | $0.03 to $0.37 | 5 | $2.92B | $2.72B to $3.57B | 7 |
Quarterly Estimates
The EPS consensus falls from $0.20 for the quarter ending Dec 31, 2026 to $0.02 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.20 | $0.12 to $0.33 | 10 | $778.95M | $656.00M to $972.30M | 10 |
| Mar 31, 2027 | $0.02 | $0.02 to $0.02 | 1 | $705.97M | $672.93M to $739.00M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 24.5% from $0.49.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.37 | $0.36 | $0.35 | $0.49 | $0.49 | -23.8% |
| Fiscal year ending Dec 31, 2027 | $0.18 | $0.21 | $0.28 | $0.63 | $0.63 | -71.0% |
| Quarter ending Mar 31, 2027 | $0.02 | -$0.02 | -$0.06 | $0.00 | $0.00 | +455.6% |
Frequently Asked Questions About SGRY
What is the SGRY stock forecast?
Consensus analyst estimates put Surgery Partners's EPS at $0.37 for the fiscal year ending Dec 31, 2026, on revenue of $3.20B. The consensus rating from 7 analysts is Hold.
How do analysts rate SGRY stock?
Of 7 analysts covering Surgery Partners, 0 rate it Strong Buy, 1 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from SGRY next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.37, with estimates from $0.37 to $0.37 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.18, with estimates from $0.03 to $0.37 from 5 analysts.
What revenue do analysts expect from Surgery Partners next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.20B, with estimates from $3.14B to $3.39B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.92B, with estimates from $2.72B to $3.57B.
How many analysts cover SGRY?
7 analysts rate Surgery Partners stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
SGRY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors